Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Inhibrx, Inc. See All Filings	D	2023-08-31 16:06:12 UTC
Amount To Be Raised $200,000,633 Associated Brokers / Dealers N/A CIK Number 0001739614 Filed Document 0001739614-23-000064 Exclusions or Exemptions 506b Accepted Date 2023-08-31 16:06:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Inhibrx, Inc. See All Filings	D	2020-04-15 18:43:52 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers N/A CIK Number 0001739614 Filed Document 0001739614-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-04-15 18:43:52 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Inhibrx, Inc. See All Filings	D	2019-05-31 13:21:54 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers N/A CIK Number 0001739614 Filed Document 0001739614-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-05-31 13:21:54 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Inhibrx, Inc. See All Filings	D	2018-05-11 11:32:43 UTC
Amount To Be Raised $75,000,000 Associated Brokers / Dealers N/A CIK Number 0001739614 Filed Document 0001739614-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-05-11 11:32:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Inhibrx, Inc. See All Filings	D	2018-05-10 13:17:13 UTC
Amount To Be Raised $410,000,006 Associated Brokers / Dealers N/A CIK Number 0001739614 Filed Document 0001739614-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-05-10 13:17:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity